The drug will also bear a boxed warning that women should not drink or take certain types of other medications, including antifungal drugs, because of an interaction that can cause low blood pressure and fainting.
Sprout Pharmaceuticals, the maker of Addyi the drug known as Female Viagra will be purchased by Valeant Pharmaceuticals for approximately $1 billion in cash, both companies announced Thursday. Sale of the company’s libido drugs will begin in October, under the brand name Addyi.
Sprout Pharmaceuticals – the company that on Wednesday won approval to sell its female libido drug “Addyi” in the US – wants to start working with worldwide drug regulators to market the product globally.
The drug, which is produced by Sprout Pharmaceuticals, is intended to treat sexual-health/hypoactive-sexual-desire-disorder.aspx” target=”_blank”>hypoactive sexual desire disorder (HSDD) – where a sufferer’s lack of sexual desire is causing them...